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Abstract 
 
Leukotrienes are specialized lipid molecules derived from arachidonic acid that have severe 
pathological roles in inflammatory diseases like asthma, allergy and in the formation of 
cardiovascular diseases. Since these diseases can be fatal if not treated, it is significant to 
study leukotriene products and how they form. The formation of leukotrienes from 
arachidonic acid is a multi step process. This event is aided by different enzymes. Two such 
enzymes are 5 – lipoxygenase (5-LO) and 5 - lipoxygenase activating protein (FLAP). FLAP 
is an integral membrane protein and belongs to the MAPEG super family (Membrane 
Associated proteins in Eicosanoid and Glutathione metabolism). In the leukotriene synthesis 
pathway, the only function of FLAP is to increase the oxygenation reaction by assisting the 
transfer of arachidonic acid from nuclear membrane to 5-LO. In fact, FLAP doesn’t seem to 
have any enzymatic/mechanistic activity on its own. Many biological questions in this 
pathway are unanswered. Is there any functional activity of FLAP? Is there any physical 
contact between FLAP and 5-LO in the leukotriene formation? To address these questions, 
we introduced a novel method of studying the pathway by constructing nanodiscs that are 
small soluble pieces of membrane of defined sizes. The aim of the project is to develop a 
protocol for generation of nanodiscs that contain FLAP (so called reconstitution of FLAP) 
and to verify the presence of FLAP in the nanodiscs by practical techniques such as blue 
native PAGE and Western Blot. Images from transmission electron microscopy were less 
conclusive but improvement can be done in future by use of antibodies to visualize FLAP 
nanodiscs. Ultimately, reconstitution of FLAP was successfully completed for further 
structural and functional studies. To conclude, this project paves way for the studies of 
complex formation of integral membrane proteins with soluble proteins and further 
applications on pharmaceutical front. 
 
 
Keywords:  FLAP, 5-LO, nanodiscs.  
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Abbreviations 
 
S.No Abbreviations Acronyms 
1 Adenosine Tri phosphate ATP 
2 Adenosine Mono phosphate AMP 
3 Charged coupled device CCD 
4 Cytosolic Phospholipase A₂ CPLA₂ 
5 Cysteinyl leukotrienes CysLT₁ 
6 Dimyristoyl phosphatidylcholine DMPC 
7 Dipalmitoylphosphatidylcholine DPPC 
8 Ethylene-di-amine tetra aceticacid EDTA 
9 Five lipoxygenase activating protein FLAP 
10 High Density Lipo protein HDL 
11 5-Hydroperoxy eicosatetraenoic 
acid 
5-HPETE 
12 Isopropyl β-D-thiogalacto- 
pyranoside 
IPTG 
13 5-Lipoxygenase 5-LO 
14 Leukotriene A₄ LTA₄ 
15 Leukotriene B₄ LTB₄ 
16 Leukotriene C₄ synthase LTC₄S 
17 Lipid to protein ratio LPR 
18 Lysogeny broth LB 
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19 Lysogeny broth agar medium LB agar 
medium 
20 Membrane scaffold protein MSP (₁E₃D₁) 
MSP (₂N₂) 
21 His tag cleaved MSP (₁E₃D₁) MSP (₁E₃D₁)- 
22 Membrane associated proteins in  
Eicosanoid and Glutathione super 
Family 
MAPEG 
23 Molecular weight cut off MWCO 
24 N-Dodecyl-β-maltoside DDM 
25 Nickel immobilized metal affinity 
Chromatography 
NI-IMAC 
26 Poly acryl amide gel electrophoresis PAGE 
27 Pichia Pastoris P.Pastoris 
28 Phosphotungstic acid PTA 
29 Sodium dodecyl sulphate SDS 
30 Superoxide dis mutase SOD 
31 Tobacco Etch Virus TEV 
32 Terrific broth TB 
33 Uranyl acetate UrAc 
34 Uranyl formate UrFo 
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Aim 
This thesis project is mainly aimed at the generation of a protocol for the formation of 
nanodiscs containing the transmembrane 5–lipoxygenase activating protein (FLAP) and 
verification of the presence of FLAP in these so called reconstituted FLAP nanodiscs. 
Introduction 
Leukotrienes are inflammatory mediators involved in many clinical diseases such as 
atherosclerosis, asthma and allergy (1). Leukocytes have the capability for the complete 
biosynthesis of leukotrienes from arachidonic acid (fig 1a) in a biosynthetic pathway that can 
be activated by a variety of external stimuli such as antigens, oxidants and immune 
complexes (20). Briefly, immunal or allergic responses trigger an increase in the intracellular 
concentration of calcium that promotes the transfer of Cytosolic phospholipase A₂  (CPLA₂) 
and 5 Lipoxygenase (5-LO) to the surface of the nuclear membrane (12). CPLA₂ initiates the 
pathway by accelerating the release of arachidonic acid stored in the nuclear membrane lipids 
for the conversion to 5-hydroperoxy eicosa tetraenoic acid (5-HPETE) that in turn is 
converted to Leukotriene A₄ (fig 1b). These conversions are mainly aided by 5-LO and FLAP 
(fig 1b) (1, 2). LTA₄ is further involved in the formation of Leukotriene B₄ catalysed by 
LTA₄ hydrolase (1). On the other hand, LTC₄ synthase can conjugate LTA₄ with glutathione 
to form LTC₄ and successive cleavage yields Leukotriene D₄ and Leukotriene E₄ (fig 1b). 
The last three products such as LTC₄, LTD₄ and LTE₄ together are called cysteinyl 
leukotrienes. LTB₄ is the potent chemo attractant for granulocytes (4). LTD₄ increases 
vascular permeability and causes mucus secretion in the respiratory tract (4). There is also 
consensus stating that cysteinyl leukotriene antagonists have an effective role in asthma (4). 
These functions suggest that there are several therapeutic applications associated with 
leukotriene inhibitors. 
 
 
                                     
Figure 1a: chemical structure of arachidonic acid (20 carbon molecules with 4 conjugated 
double bonds) 
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Figure 1b: Role of FLAP in the synthesis of Leukotrienes (2) 
 
 
As said before, leukotrienes in general have been identified as mediators for a variety of 
diseases (1). Furthermore, 5-LO was investigated in several diseases such as asthma, 
atherosclerosis, and bone related diseases such as osteoporosis, rheumatoid arthritis, and even 
prostate cancer (17). Knockout mice experiments suggests that 5-LO plays a significant role 
in rise of airway hyper responsiveness (19) as well as in atherosclerosis (17). Mice with a 5- 
LO knockout allele was found to show decrease in aortic lesions growth. These researchers 
also observed that in aortic lesions of Apo-lipoprotein E (-/-) lacking mice, 5-LO prolifically 
expressed especially in macrophages (17). Similarly, knock out studies were carried out in 
mice on osteoporosis, a bone related disease (19). It was observed that mice which lack the 5-
LO gene showed dramatic increase in cortical bone thickness and also many differences in 
mechanical properties of bones. 
 
Knock out studies in FLAP were also carried out with mice as an experimental model. Lack 
of this activating protein was identified to give vulnerability to cardiovascular diseases such 
as atherosclerosis and stroke (17). FLAP deficient mice clearly proved an involvement of 
leukotrienes in the pathogenesis of respiratory diseases such as asthma (17). To combat 
against these diseases, 5-LO inhibitors and FLAP inhibitors proved to be very effective for 
producing drugs. To name a few, zafirlukast, zileuton, pranlukast were the potential inhibitors 
for the respiratory diseases. FLAP inhibitors such as MK 886, MK 0591 and BAY X 1005 
inhibit leukotriene synthesis in isolated human polymorphonuclear cells (4). 
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Five lipoxygenase, 5-LO 
 
Human 5-LO is a monomeric enzyme with 673 amino acids (fig 2) and a molecular weight of 
78 kDa. The crystal structure of human 5-LO was published recently and can be seen as a 
cylinder about 100 Å long and 60 Å in diameter (PDB: 308Y) (16). The structure consists of 
an N-terminal domain with 114 amino acids and a C terminal domain which has amino acid 
residues 121 to 673. The N-terminal β-sandwich domain confers calcium induced membrane 
binding, whereas the C-terminal domain is mainly alpha helical and contains a catalytic iron 
ion (16). The structure shows that the iron is anchored by two conserved Histidine residues, 
the C–terminal Ile-673, Asn-554 and a water molecule (16). Electron paramagnetic studies 
suggests that recombinant 5-LO iron is in ferrous state (Fe2+) and when it interacts with 5-
HPETE, it turns into the ferric state (Fe3+) (15). The stability of human 5-LO is significant to 
study since this enzyme turns hypersensitive and loses activity when exposed to oxygen (15). 
Mutant 5-LO was proven to be highly successful in terms of stability and has a longer half-
life compared to the wild type 5-LO (16) and this was, in fact, the key for the crystallisation 
of human 5-LO (16). For the wild type enzyme to remain active, stabilizing agents such as 
ATP and superoxide dismutase were added. If either of these is not added, enzyme loses its 
activity within 10 hrs after purification (15, 16). 
 
                              
 
Figure 2: Structure of 5-LO (Ferrous form of human 5 LO) PDB: 308Y (16) 
 
The N-terminal β-sandwich is similar to the C2 domain of CPLA₂ and amino acids in certain 
loops adheres to calcium and embeds in the membrane and it was shown that a minimal 
concentration of calcium is sufficient for this activation (15). The function of Calcium is to 
recruit 5-LO, CPLA₂ and many other enzymes to the nuclear membrane (12). In some cases, 
when doing in-vitro experiments, Mg2+ (Magnesium) may activate 5-LO (15). Furthermore, 
the interaction with membrane phospholipids increases the activity of 5-LO in vitro (15). 
 Five-lipoxygenase activating protein, FLAP 
Membrane proteins present in our body promotes significant contribution to cell functions 
such as cell communication or acts as transport machinery (3). Statistics say 50 % of the drug 
targets are membrane proteins (3). One among these membrane proteins is FLAP (Five 
Lipoxygenase Activating Protein). In the late 1980s, scientists identified an indole class 
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compound named MK 886 that inhibited the leukotriene synthesis without affecting 5-LO 
(4). The use of photo affinity analogue of MK 886 identified an 18 kDa integral membrane 
protein called FLAP (21). The function of FLAP is, as the name suggests, to activate 5-LO 
and does so by helping and presenting arachidonic acid to 5-LO (1, 2, 4) with an unknown 
mechanism. A proper enzymatic activity of this protein is not known till now. The total 
sequence length of FLAP is 161 amino acid residues and is similar to human LTC₄ synthase 
as it shares 33 % sequence identity to it (1).  
Structure of FLAP 
The X-ray crystal structure of FLAP in complex with the inhibitor MK 591 and the iodinated 
analogue of MK 591 was solved to 4.25 Å (PDB: 2Q7M) and 4.00 Å (PDB: 2Q7R) (5). Each 
monomer consists of four transmembrane helices (ɑ1-ɑ4) that are connected by two cytosolic 
loops and one luminal loop (5). The functional unit of FLAP is a trimer of molecular weight 
54 kDa. 
                                                   
 
 
Figure 3a: FLAP structure as trimer (PDB: 2Q7M) 
 
Figure 3b: Top view of FLAP structure (PDB: 2Q7M) 
 
Fig 3a, 3b shows the graphical representation of the FLAP structure generated with the 
chimera software (inhibitors not shown but are located in pockets between each subunit). Fig 
3a reveals the side view and fig 3b is the top view of human FLAP (PDB: 2Q7M). The whole 
     60Å 
36Å 
36 Å 
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trimer is cylindrical in shape which measures about 60 Å high and 36 Å in diameter. It is 
found that the C-terminus of the FLAP structure is highly disordered beyond G140 residue 
and continues in the lumenal region (5). As mentioned before, although the X-ray crystal 
structure of FLAP is already known, the mechanism for the activity of FLAP is not yet 
identified. In this project, the FLAP protein is studied using a novel approach called 
nanodiscs.  
Nanodiscs and Membrane proteins 
Just as for soluble proteins, it is important to have membrane proteins isolated in a stable 
form and free from impurities for structural as well as functional studies. However, 
membrane proteins are located in lipid environment. Hence, they need to be solubilised from 
the membranes by the use of detergent and can be maintained stably and kept active in a 
solubilised state in mixed protein-detergent micelles (7). Many membrane proteins require 
specific types of phospholipids for active function, sometimes a requirement which is not 
satisfied even by mixed detergent-lipid micelles. Altogether, detergent solubilisation may 
sometimes lead to activity loss and problems in analysing the protein due to heterogenecity 
and aggregation. For stabilisation, reconstitution of membrane proteins into liposomes is 
considered to be successful despite some limitations such as the size factor (large in size) and 
that they are difficult to prepare with exact stochiometry of protein per vesicle (7). Nanodisc 
is another approach, where the enzymatic function as well as the structural aspects of 
membrane proteins can be studies in a membranous environment (fig 4) (6).  
             
 
Figure 4: Schematic view of nanodiscs. Lipids (green) with a schematic protein (grey) 
stabilized by two amphipathic belts of membrane scaffold proteins (blue) 
 
Structure of nanodiscs 
Nanodiscs are circular fragments of phospholipid bilayer which are encircled by two copies 
of membrane scaffold proteins (MSP) and the longer MSP the larger diameter of the disc (6, 
7). An illustration of how membrane protein oligomers can be assembled depending on the 
size of nanodiscs is how monomeric rhodopsin reconstituted into smaller MSP₁ D₁ whereas 
trimers reconstituted in the longer MSP₁ E₃ D₁ (6). The choice of MSP, lipids and even 
detergents is significant for preparing nanodiscs and has to be optimised for correct 
stochiometric ratios (6, 7). For this project, it is important that one FLAP and one 5-LO can 
form a complex and hence the size of the nanodisc is correctly chosen. 
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Origin of MSPs 
Membrane scaffold proteins are derived from genetically engineered versions of 
apolipoprotein A₁ which have the property of forming circular amphipathic belts upon 
accurate addition of lipids and complete removal of detergents (6, 23). This forms nanodiscs 
called High Density Lipoprotein (HDL) that are involved in the cholesterol transport (24). 
The apo-lipo protein A₁ is predicted to contain ten amphipathic alpha helices (H₁-H₁ₒ) and an 
N-terminal stretch which does not have the property of disc formation but seemed to make 
nanodisc preparations less homogenous. Hence, researchers cut away that region and created 
a version of MSP named MSP₁ D₁ yielding a disc size 9.7 nm, same as with the original 
apolipoprotein A₁ (6). Later, for efficient reconstitution of dimers, trimers and complex 
studies with larger proteins that require more disc space not compatible with the shorter 
version MSP₁ D₁, an extended version of MSP₁ D₁ was made (6). Larger disc size was 
achieved by insertion of a repeat of helices 4, 5 and 6 (denoted E3) between helix 3 and helix 
4 which yielded a disc of 12.8 nm. The variant is named MSP₁ E₃ D₁.  Furthermore, these 
MSPs contain an N-terminal hepta-histidine tag followed by a TEV protease cleavage site, 
useful for separating reconstituted discs from empty discs. Membrane proteins may not have 
this specific engineered TEV protease cleavage site, even if they contain a His-tag. Hence, 
purification of reconstituted discs can be achieved by using commercially available 
engineered TEV proteases. In this project, two different types of TEV proteases were used. 
Furthermore, an extended version of MSP₁ E₃ D₁  was made named MSP₂ N₂ with disc size 
of 16.5 nm (6). These larger discs were achieved by fusion of MSP₁D₁-11 and MSP₁ D₁-22 
tagged with a GT-linker. In this project, both MSP₁ E₃ D₁ and MSP₂ N₂ were used. The 
molecular weight and extinction coefficients of MSP₁ E₃ D₁ and MSP₂ N₂ have been 
estimated at 32 kDa, 45 kDa and 29,910 Mˉ¹ cmˉ¹ and 39,430 Mˉ¹ cmˉ¹ respectively (6). 
Advantages of nanodiscs 
There are several distinct advantages with reconstitution of membrane proteins into 
nanodiscs. Nanodiscs are very stable and planar. They are render membrane proteins soluble 
in aqueous solutions and provide native like bilayered surroundings. Membrane proteins 
reconstituted in the nanodiscs are maintained monodisperse and highly active (3, 6, 7). 
Membrane proteins inside the disc are easy to access from either side of the membrane. The 
overall focus of the project in the group is to reconstitute FLAP into nanodiscs for subsequent 
analysis of structure and activity of 5-LO with the FLAP-containing discs in the presence and 
absence of calcium. This might open up for understanding the role of FLAP in the 
biosynthetic pathway (fig 1b). 
 
Limitations of nanodiscs 
Apart from advantages, there are also some limitations of nanodiscs. From the experimental 
results of this project, it is identified that the prepared nanodisc sample is stable only for a 
month at a temperature of 4 °C. However, recent results from reconstitution experiments on a 
membrane protein proved that discs could be stored at -80 °C with no harmful effects due to 
thawing (Natalya Fedosova, Department of Biomedicine, Aarhus University). When 
compared to vesicles, nanodiscs are more costly and preparation consumes more time. In 
transmission electron microscopic images, the diameter of the disc may vary slightly when 
compared to the actual disc size. Nanodiscs are not suitable for activity measurements of 
transporter proteins that need different environments for the two sides of the protein.  
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Methods 
 
Bacterial expression of MSP₁E3D1 and MSP2N2 (strain used: BL21 (DE3)) 
LB Agar medium (appendix 2) was prepared and autoclaved. Plasmids (pET 28a, Addgene 
Co) were thawed and incubated in ice for 30 minutes. Ten micro litre of plasmid was taken 
and mixed with competent cells and incubated on ice for 30 minutes. The cells were heat 
shocked at 42 °C for a minute and immediately put on ice for a minute. LB medium (900 µl) 
was taken to grow these cells at a temperature of 37 °C for one hour. Transformed cells were 
poured uniformly in each LB agar plate containing 20 µg/ml ampicillin antibiotic and kept at 
37 °C overnight. 
 
Preparation of starting culture 
LB medium (5 ml) was prepared with 100 µl of kanamycin antibiotic (Duchefa biochemie 
Inc) was added to the culture. Streaks of MSP1 E3 D1 and MSP2 N2 plasmid (Addgene Co) was 
added to the medium containing antibiotic in separate plates and kept in a rotary shaker at a 
temperature of 37 °C for nearly 20 hours. Meanwhile, one litre Terrific broth medium was 
prepared by mixing 47 g/l commercially available terrific broth powder (Invitrogen) with 
distilled water and autoclaved at 121 °C. 
Expression of MSP1E3D1 and MSP2N2 
Overnight cultures were inoculated in one litre terrific broth medium containing kanamycin 
antibiotic and incubated in a rotary shaker at 37 °C, 200 rpm. OD values were checked at an 
interval of one hour. When the OD value was 0.275-0.3, 1 mM isopropyl β-D-
thiogalactopyranoside was introduced to induce protein expression. In the case of MSP₂  N₂, 
after IPTG induction the temperature was reduced to 28 °C and kept in shaker for another 
three hours. However, for MSP₁   E₃   D₁ temperature remained unchanged at 37 °C after 
induction with IPTG. After three hours, the cells were centrifuged at 7500 rpm for 15 minutes 
and the pellet containing protein was resuspended with phosphate buffer (appendix 2, pH: 
7.4) and stored at -80 °C. 
NI-IMAC 
Since, His-tagged proteins have high binding affinity for nickel ions, Nickel sepharose 
column (GE healthcare) was chosen for purification. In immobilised metal ion affinity 
chromatography, the interaction takes place between metal ions and histidine tagged proteins. 
Bound proteins can be eluted by adding high concentration of imidazole. 
Purification of MSP (Both MSP1E3D1 and MSP2N2) 
Cell pellets stored at -80 °C were taken from the deep freezer and were kept on ice. EDTA-
free protease inhibitor cocktail tablet (Roche) was added to prevent proteolysis. Triton-X-100 
detergent of concentration 1 % was also added to the mixture. For the cell to lyse, sonication 
was performed with ice surrounding the mixer for 12-13 times at an interval of 10 minutes. 
After sonication, the lysed culture was centrifuged at 17000 rpm for 45 minutes. The 
supernatant was collected and kept on ice in order to avoid degradation. The nickel sepharose 
column was regenerated with 50 mM EDTA/50 mM Tris buffer. Then, it was washed with 4 
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column volume of water. 0.1 M nickel chloride was prepared and loaded into the column. 
After constant washing with water, the column was equilibrated with 4 column volumes of 
phosphate buffer. After equilibration, the supernatant was loaded onto the column followed 
by wash buffer 1, 2 and 3 (appendix 2) collected in separate tubes. Finally, Proteins were 
carefully eluted with elution buffer containing high concentration of imidazole. 
Buffer exchange and concentration 
Using PD -10 column (GE Healthcare), buffer exchange was conducted of protein solutions 
to MSP elution buffer (GE Healthcare procedure, appendix 2). The eluted protein was 
concentrated using AMICON ultra tube (10,000 Molecular weight cut off). The concentration 
of protein was measured with the help of quartz cuvette using UV spectrophotometer (Cary-
4E UV Spectrophotometer) at 280 nm. The extinction co-efficient of MSP₁ E₃ D₁ is 29910 M-
1 cm-1 and of MSP₂ N₂ it is 39430 Mˉ¹ cm¯¹. MSP₁ E₃ D₁ (-) where the His-tag has been 
cleaved off has a molecular weight of 29.9 kDa and an extinction coefficient of 26600 Mˉ¹ 
cmˉ¹. 
SDS-PAGE 
The protein purification (MSP1 E3 D1, FLAP and 5-LO) was monitored by SDS-PAGE using 
12 % homogeneous gels. After the run, proteins were stained with Coomasie reagent and 
destained with methanol/acetic acid alternatively with water. MSP1 E3 D1, FLAP and 5-LO 
were detected based on the molecular weight of 32.6 kDa, 18 kDa and 78 kDa respectively 
(see fig 7). 
Purification of FLAP 
The expressed human FLAP with a hexa-histidine tag from Pichia pastoris species (MBB, KI 
Solna) pellet stored at -20 °C was taken for purification. Since, membrane proteins degrade 
easily pellets taken from the freezer were stored in ice in the cold room. Cell lysis was 
performed with glass beads of 0.1 mm using blender for 7 times with 10 minutes interval. 
After cell lysis, the solution was filtered through filter paper. The filtered solution was 
centrifuged at 8000 rpm (JA-10 rotor, Beckman J2-MC centrifuge) for 20 minutes at 4 °C. 
The supernatant was collected and the pH was adjusted to 7.6. To the solution, 0.1 % DDM 
and 5 mM β-mercaptoethanol was added. β-mercaptoethanol acts as a reducing agent. The 
mixture was kept one hour on ice to solubilise and was then centrifuged at 12000 rpm for 20 
minutes at 4 °C and the supernatant was kept on ice for purification. The nickel-IMAC 
column was equilibrated with FLAP buffer (appendix 2) which contains 0.1 % DDM. 10 mM 
imidazole was added to the collected supernatant and loaded into the equilibrated column. 
The solution was collected as crude. Then, series of washes were performed with wash buffer 
1 and 2 (appendix 2) and the FLAP protein was eluted using FLAP elution buffer (appendix 
2). Buffer exchange was completed using PD-10 column (GE Healthcare) and concentrated 
using AMICON (Millipore) tubes. The concentration was checked using UV 
spectrophotometer. The extinction co-efficient of FLAP is 19031 Mˉ¹ cmˉ¹. 
 
5-LO expression (Strain used: BL21 (DE3)) 
Starter culture (E. coli) containing 0.1 mg/ml ampicillin as antibiotic was prepared and kept 
at 37 °C for 20 hours. After sufficient bacterial growth, 5 ml of the overnight culture was 
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inoculated to the prepared medium (M9, minimal medium) containing 0.1 mg/ml ampicillin 
and kept at rotary shaker at 25 °C. After six hours, 0.25 mM IPTG was added for induction 
and the culture was incubated in rotary shaker for 14-16 hours. The grown culture was 
centrifuged at 7000 rpm for 20 minutes (Beckman J2-MC, rotor JA: 10). Pellet containing 
protein was collected and resuspended with the prepared lysis buffer (Appendix 2) and stored 
at -80 °C. 
5-LO purification 
The cell pellet stored at -80 °C was thawed and kept on ice for purification. 0.001 g of 
DNase, 0.5 mg/ml lysozyme, half a tablet of EDTA free protease inhibitor and 5 mM β-
mercaptoethanol was added to the lysis buffer. Sonication was performed for the cells to lyse 
for 14 times at an interval of 10 minutes each. The final clear lysed culture was centrifuged at 
18500 rpm for 100 minutes. Supernatant was collected separately. 
ATP-agarose column 
Since 5-LO has strong binding affinity with ATP, ATP-agarose column (Sigma Aldrich) was 
used for purification, and equilibrated with 3 column volumes of lysis buffer. After 
equilibration, 10 ml of sample was loaded into the column and collected as crude. 5 ml of 
wash buffer 2 (appendix 2) was poured into the column followed by 5 ml of wash buffer 1. 
After these steps, one column volume of wash buffer 1 (appendix 2) was loaded for final 
wash followed by AMP elution (appendix 2) with 20 ml of AMP elution buffer. 5-LO was 
eluted with 30 ml of ATP elution buffer (appendix 2) and collected separately. The collected 
samples were concentrated using AMICON (Millipore) tubes (10,000 MWCO) followed by a 
buffer exchange (PD-10 column, GE Healthcare, MSP standard buffer) and concentrated (if 
needed) and stored in ice. 20 µl of the purified protein was taken for loading in SDS PAGE 
and the protein was detected at expected molecular size (78 kda) as shown in fig 7. Since 5-
lipoxygenase is very unstable and loses its activity quickly when exposed to oxygen, the 
stabilizing agents glutathione peroxidise 0.15 µg/ml (Sigma-Aldrich Inc), superoxide 
dismutase 1.5 µg/ml (Sigma-Aldrich Inc) and 12 mM ATP were added and the material was 
stored at -20 °C for future use (9).  
Choice of lipids and MSPs 
 
Researchers in the past worked on reconstitution of membrane proteins with different lipids 
such as DPPC, DMPC, and POPC (6). In this project, the lipid used was POPC (1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (Avanti Co). The main reason for choosing POPC 
among other lipids is 5-LO binds to phospholipids specifically containing an unsaturated acyl 
chain at the sn-2 position with the strongest binding to PAPC but the binding to POPC is also 
very strong since the oleoyl group contains one unsaturated binding. Hence, POPC was 
considered as an ideal choice in this project for preparing nanodiscs since this lipid has been 
used in the MSP research (6,7). The molar ratio of lipid to proteins (LPR) is also very 
significant in the preparation of empty discs. In this project, the molar ratio of POPC: MSP₁ 
E₃ D₁ for empty discs was xxx:1. There are different versions of engineered MSPs available 
for the research purpose (6). In this project, we first tested making empty discs with MSP₂N₂. 
However, for reasons described later in the discussions, MSP₁ E₃ D₁ was used for 
reconstitution. For the purpose of reconstitution, the surface area of the nanodisc 
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phospholipid bilayer needs to be matched to the size of the target protein chosen to be 
assembled.   
Preparation of detergent solubilized lipids 
Lipid stocks in chloroform (25 mg/ml) were stored at -20 °C. Since POPC is dissolved with 
chloroform, it was added in a round bottomed flask with appropriate volume and was dried 
under nitrogen gas. After a period of time, a thin white film was seen around the round 
bottomed flask ensuring the removal of chloroform. To remove it completely, the flask 
containing dried lipid was kept under high vacuum in a vacuum desiccator overnight. This 
ensures that the flask contains only a known amount of lipid to the desired concentration. 
Sodium cholate (Sigma-Aldrich Inc) was added to the lipid in the molar ratio of 2:1. The 
tubes were heated in a hot water and sonicated in an ultrasonic bath until it appeared as a 
clear solution. After a few minutes, tubes containing detergent solubilised phospholipids were 
taken out and stored at -80 °C for future use. Sodium cholate is recommended (6) but other 
detergents can be tested if a target membrane protein is not stable in cholate. 
Preparation of empty discs 
Membrane scaffold proteins were added to the cholate solubilised phospholipids taken from 
the deep freezer according to the calculated lipid to protein ratio. The calculated LPR (lipid to 
protein ratio) for preparing empty disc is 120 for MSP₁ E₃ D₁ and 240 for MSP₂ N₂. The final 
cholate concentration in the mixture should be between 12-40 mM (6). In this project, the 
final concentration of sodium cholate was optimised and found to be xx mM for empty MSP₁ 
E₃ D₁ discs. The assembly mixture was kept on ice for one hour. After one hour, two third 
volumes of bio beads (SM-2 adsorbent, Bio-Rad) were added to remove the detergent. The 
tubes were kept in a rotary shaker at 4 °C overnight. The tubes were taken out the next day 
for removing bio beads from the solution. Empty discs get assembled automatically upon 
complete removal of detergent. The solution was stored at 4 °C and 10 µl was taken for blue 
native PAGE analysis (4-12 % Bis-Tris gel, Invitrogen Inc). The calculated molecular weight 
of an empty MSP₁ E₃ D₁  disc and empty MSP₂ N₂ disc is 242 kDa and 454 kDa respectively. 
The prepared empty discs can be stored at 4 °C for 30-40 days. However, later it was found 
that deep freezing the empty discs at -80 °C is also a possible option for long term use. 
Reconstitution of FLAP 
Reconstitution of FLAP into MSP₁	  E₃	  D₁ nanodisc was performed according to the protocol 
designed as stated in appendix 3. Better results were obtained when incubated at 4 °C than at 
37 °C due to the use of POPC (6). 
Separation of empty discs from reconstituted FLAP nanodiscs 
The prepared reconstituted FLAP disc sample contains both FLAP nanodiscs and empty 
discs. It is very difficult to analyse the structural properties of any proteins when it is not in 
pure state. Hence, it is important to separate the empty discs from the reconstituted FLAP 
nanodiscs. Since the engineered MSPs contain a TEV cleavage site after the hepta-histidine 
part in its sequence, a TEV protease was used to cleave the His-tag and the disc samples were 
purified using a histidine spin trap column (GE Healthcare). The FLAP protein does not have 
a TEV protease cleavage site and hence the reconstituted FLAP nanodiscs are retained in the 
column while the empty discs elute. In this project, TEV proteases from both Invitrogen and 
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Sigma-Aldrich Inc were used where both contained hexa-Histidine tags but had different 
molecular weights.  
AcTEV protease from Invitrogen 
Purified MSP₁  E₃  D₁ was used for cleavage with this engineered TEV protease. The idea is to 
cleave the His-tag before performing the reconstitution. MSP₁  E₃  D₁ was diluted with TEV 
buffer (50 mM Tris pH: 8.0, 0.5 mM EDTA and 1 mM DTT) mixed with AcTEV protease in 
the ratio of 1 unit enzyme to 3 µg of substrate. The mixture was prepared to the final volume 
of 150 µl and incubated at 30 °C for 3 hours. After 3 hours of incubation, the sample was 
taken for purification using histidine spin trap column (GE Healthcare). After regenerating 
the spin trap column, 0.1 M NiCl2 was added and column was equilibrated with MSP buffer 
(appendix 2). Crude containing empty disc and reconstituted FLAP was added to the column 
and centrifuged at 1000 rpm for 30 seconds. Cleaved MSP₁  E₃  D₁ elutes out retaining the 
histidine tag from the protein and some TEV protease in the column. Cleaved protein was 
analysed using 12 % SDS PAGE. The molecular weight of TEV protease is 25-28 kDa and 
cleaved MSP₁  E₃  D₁ is 29 kDa. 
TEV protease from Sigma-Aldrich 
Previously, purified MSP₁  E₃  D₁ was taken for the cleavage reaction. But, the protocol was 
slightly changed for the cleavage reaction performed with this TEV protease (Sigma Aldrich 
Inc). In this method, FLAP protein was reconstituted in the disc and then the TEV protease 
was added to perform the cleavage reaction in the ratio of (1:100 w/w), i.e. one mg of TEV 
protease to 100 mg of target protein and the crude was incubated at 4 °C for 16 hours. During 
the incubation time, TEV protease initiates its activity by cleaving the His-tag from the MSP 
protein where it leaves the FLAP protein His-tag which does not contain the specific cleavage 
site. After the specified time, separation was completed using a His-column, where the empty 
discs elute first using the MSP wash buffer 1 (appendix 2) and FLAP discs using Zeba spin 
desalting column (40k MWCO). The equilibration buffer used was 25 mM Tris, pH: 8, 150 
mM NaCl, 14 mM β-Mercaptoethanol. 
Western blot 
After reconstitution of FLAP, it is necessary to do the confirmation tests to indicate the 
presence of FLAP in the nanodiscs. For this, an analytical technique western blot was 
preferred. The principle behind this technique is to detect the proteins with the help of the 
specific antibodies. This involves several steps such as preparation and running of PAGE gel, 
visualization of proteins in the gel, transfer of proteins from the gel to PVDF or nitrocellulose 
membrane, blocking the membrane, incubation with primary and secondary antibody and 
development. In this experiment, we used one hour western blot detection kit (Genscript Inc). 
It reduced the time and increased the sensitivity of the technique when compared to classical 
western blot method. The primary antibody anti ALOX 5AP / FLAP from rabbit IgG was 
purchased from Acris Gmbh, Germany. 
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Confirmation of FLAP nanodisc by SDS-PAGE 
 
The first experiment was to compare the preparation of FLAP in nanodiscs to FLAP in 
detergent micelles using denatured gel electrophoresis. The process is initiated by running 
SDS-PAGE. 12 % gel was prepared from 40 % bis – acryl amide (Bio-Rad, CA). 0.01 g 
Ammonium persulfate and TEMED was added to initiate polymerization. After the 
preparation of separation and stacking gel, the protein sample was mixed with 2x SDS buffer 
and heated at 60-70 °C for the proteins to denature and loaded on the gel. The entire set up 
was kept at 100 kV for five to ten minutes to allow the sample to migrate from stacking gel to 
separation gel and then changed to 150 kV for 70-90 minutes. During the running time, 1X 
Tris-glycine buffer (with 0.1 % SDS) was prepared. Blotting pads were soaked with the 
buffer for 30-45 minutes. It is necessary to remove all the bubbles sticking on the pads as it 
may disturb the transfer of proteins. In this experiment, nitrocellulose membrane (7.5-8.0 cm) 
was used. It was soaked in methanol for 30 seconds prior washing with water and membrane 
was incubated in 1X transfer buffer for nearly 60 minutes. 125 ml of 1X wash solution was 
prepared from 5X wash (Genscript Inc) taken from the kit and kept ready for further washing 
steps. 10 µg of anti-FLAP (Acris Gmbh, Germany) which is a primary antibody was prepared 
by mixing with WB-1 Solution (Genscript Inc) and kept at room temperature for 40 minutes. 
This is called mixture 1. This step is completed either during protein transfer or before the 
transfer and incubated as said above. As soon as the SDS-PAGE is complete, the gel was 
carefully taken from the glass plate and kept for transfer. The soaked blotting pads were kept 
at the cathode end. A Filter paper was placed above the blotting pads with gel facing the top 
and then the nitrocellulose membrane. Care must be taken to avoid bubble formation on the 
membrane. It is necessary to use the glass pipette to roll over the membrane, blotting pads to 
ensure the set up is completely free from bubbles. Again, the same arrangement was placed 
on the top of the membrane with blotting pads on the anode end. The entire set up was 
packed tightly and kept at 25 V for 90-120 minutes. With the one hour western blot kit, 
blocking and binding of secondary antibody steps was quick with the help of pre treat 
solutions and WB-2 solution (Genscript Inc). Pre treat solution mixture was prepared by 
mixing pre treat solution A and pre treat solution B (Genscript Inc). As soon as protein 
transfer to membrane is complete, it was placed in the prepared pre treat solution mixture and 
rinsed with 1X wash solution (15). The primary antibody with WB-1 (Mixture 1) was mixed 
with 10 ml of WB-2 (Secondary antibody) and membrane was kept in the solution on a 
shaker for overnight. After the specified time, membrane was rinsed with 1X wash solution 
(15). 
For development, Lumisensor™ chemiluminescent HRP substrate (Genscript Inc) was used. 
1.5 ml of reagent A was mixed with reagent B and vortexed for few seconds. The working 
solution was prepared. 10 µl -20 µl of the working solution was sufficient to cover the entire 
membrane. Membrane was immersed with the working solution and kept for three minutes. 
Tissue papers were used to drain the excess solution. After few minutes, the membrane was 
pictured using Gel doc scanning machine (Bio-Rad Inc) with different exposures at 
subsequent intervals.  
Confirmation of FLAP nanodisc by native PAGE 
The main difference was that the gel runs in a native non-denaturing environment. Native 1X 
Tris-glycine buffer (without SDS) was used for the initial gel run. The remaining steps till 
development are the same (15).  
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Analysis of sample by Electron Microscope 
 Negative staining 
 
Negative staining is not a novel technique for protein structural studies, it has a long history 
and it is still proven to be useful for studying several macromolecular assemblies (10). There 
are both limitations and advantages of using this method. Image resolution is restricted since 
the heavy metal stains replicates the outer rim of the protein and thus makes the structural 
information very limited. Another problem is artifacts and distortions in the images due to the 
stains. Despite some limitations such as positive staining, uneven staining, this method has 
many advantages. This method yields high contrast images due to strong scattering of the 
heavy metals in the staining agents (10). The stained sample is less prone to radiation damage 
compared to ice grafted samples. In this experiment, negative stains such as PTA 
(Phosphotungstic acid), uranyl acetate (UrAc) and uranyl formate (UrFo) were used. Each 
and every stain has different properties and it is reflected in the EM pictures of the empty 
discs as well as reconstituted FLAP.  
 
Specimens were made by using circular net (400 mesh) coated with carbon called “grids” 
made as follows. A thin layer of carbon was evaporated on the top of automatically flat mica 
sheets. The carbon film was then transferred from mica to the grids. Since the carbon is 
hydrophobic material, it was made hydrophilic to make the surface of the grid more 
approachable to water as well as stained sample. This can be done by a method called “Glow 
discharging”. Carbon coated grids were placed in a vacuum filled chamber connected to 
power supply. After placing the grid, high voltage at the range of 30 mA for 20 seconds was 
applied. After the application of high current, the electron potential ionizes the gas inside the 
chamber, which makes the negative charged ions to fix on the carbon to make a hydrophilic 
material.  
Staining procedure for empty discs and reconstituted FLAP discs 
Empty disc samples of both MSP2 N2 and MSP1 E3 D1 were kept on ice. Concentrations of 
both disc samples were determined using UV spectrophotometer and were found to be 0.65 
mg/ml and 0.56 mg/ml respectively. Carbon coated grids were taken from the glow 
discharging and fastened with the help of tweezers (Dumont Inc). 4 µl of empty disc sample 
was incubated on the grid for 60 seconds. After this step, grids were gently washed with three 
droplets of water and drained immediately using Whatman filter paper no 4. This step is to 
remove any salt content or impurities other than proteins fixed on the grid. Before drying out, 
the grids were then stained with 1.5 % PTA, 1 % UrAc or 1 % UrFo and then air dried at 
room temperature for 5-10 minutes. The staining procedure for reconstituted FLAP discs was 
similar to that of empty disc preparations. However, later it was found that the concentration 
of reconstituted FLAP discs was too high to see the discs clearly in the microscope. The 
optimal concentration of reconstituted FLAP nanodiscs used in this experiment was 0.15 
mg/ml or even lower for clear microscopic images.  
Electron microscopy 
Nanodiscs images were captured with the help of transmission electron microscope CM120 at 
120 kV and JEOL2100F at 200 kV using a CCD camera with either (1024 x 1024) pixels or 
(4096 x 4096) and 25 µm and 15 µm pixel size respectively. 
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Results and Discussion 
 
 MSP₂N₂ 
The aim of this project is the reconstitution of FLAP into nanodiscs, however, in the overall 
project to study complex formation with 5-LO the area of the nanodisc needed to be chosen 
to have space for both FLAP and 5-LO. The diameter of FLAP is about 36 Å (fig 3b) and the 
area it occupies in the membrane calculated to be about 1020 Å2. The 5-LO was reported to 
be about 100 Å long and 60 Å wide (16) and that an area of at most 9600 Å2  makes contact 
with the membrane although the effective area may be only 7200 Å2 (14). The MSP₂ N₂ was 
initially chosen for the large disc size of 145 Å inner diameter (bilayer area of 16500 Å2) 
(11).  
  
 
                                 
 
 
Figure 5a: purified MSP2 N2 (12 % SDS 
PAGE) 
Figure 5b: MSP2 N2 Proteolysis effect (12 % 
SDS PAGE 
 
 
 
Fig 5a indicates the purified MSP2 N2 at 45 kDa. This sample is the freshly purified protein 
prepared with the addition of EDTA free protease inhibitor tablets. The sample was stored at 
4 °C for preparing empty discs and reconstitution studies. The same sample was tested in 
SDS PAGE after few weeks of storage at 4 °C. Unfortunately, it was found that there was a 
problem with instability of the MSP₂  N₂ preparation and that SDS-PAGE analysis indicates 
that proteolysis occurred as seen in lane B, fig 5b. Simultaneously, another MSP2 N2 sample 
was purified without the addition of protease inhibitor tablets to check the nature of MSP₂ N₂. 
Proteolytic degradation was seen clearly as shown in lane A, fig 5b. Therefore, it was found 
that this MSP₂  N₂ is not stable enough for the reconstitution studies and hence MSP1 E3 D1 
was considered for further studies in this project. Though the size of the MSP₁  E₃  D₁ disc is 
small compared to MSP₂  N₂, there is enough space for reconstitution of FLAP and binding of 
5-LO. Considering the size of MSP₁ E₃ D₁ disc of 10.8 nm inner diameter (9600 Å2) and 
sizes of FLAP and 5- LO (as shown in Fig 3a, 3b), it is assumed that one can incorporate one  
FLAP (and probably one 5- LO) inside the MSP₁ E₃ D₁   nanodisc. Considering the time 
factor and also the stability of the MSP₁ E₃ D₁, reconstitution studies of FLAP into nanodisc 
were performed on this 12.8 nm (outer diameter) sized scaffold protein.  
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Empty nanodiscs from MSP2 N2 
 
 
                       
 
                
Figure 6: EM picture of empty discs with MSP₂N₂ (35 kX) stained with 1 % PTA 
 
 
Earlier when researchers worked with nanodiscs such as HDL (24) they used the negative 
stain PTA (Phosphotungstic acid), and found more or less aggregation of the discs bilayer to 
bilayer in long “stacks” and not free lying discs on the grids (24). Later when Uranyl acetate 
was used they found that the discs could separate (24). For this thesis project the stacking 
could be a useful tool. Empty discs should stack but for nanodiscs containing a membrane 
protein that sticks out from the membrane there should be no stacking. 
 
Fig 6 shows the stacking formation of MSP₂ N₂ empty discs stained with 1 % PTA. The 
arrow in the picture depicts the homogeneous pattern of side view of the stacked discs, one 
over the other. The width of the long stacks are about 17.5 nm as expected for the MSP₂ N₂ 
discs and the distance between the stripes is about 5 nm as expected for stacks of membrane 
bilayers (6). The concentration of the empty disc was 0.65 mg/ml and the LPR used for the 
preparation of empty disc was “240”. The molecular weight of the MSP₂ N₂ empty nanodisc 
was calculated at 450 kDa. 
 
 
 
 
 
 
 
Three stacks of 
nanodiscs, diameter – 
17.5 nm 
Distance between 
 each stripes in the 
stacks – 5 nm 
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Results from expressed and purified proteins 
 
 
                                    
 
 
 
Figure 7: 12 % SDS PAGE analysis of Purified MSP1 E3 D1, FLAP and 5-LO 
 
Due to the stability problem with MSP2 N2, MSP1 E3 D1 was used for purification and further 
reconstitution studies. The necessary proteins used in this project MSP1 E3 D1, FLAP and 5-
Lipoxygenase were purified and analysed with SDS-PAGE as shown in fig 7. To explain 
precisely, Lane 1 shows the MSP1 E3 D1 scaffold protein at molecular weight 32 kDa. Lane 2 
shows the FLAP protein at 18 kda and lane 3 shows 5-LO at 78 kDa. 
 
 Empty nanodiscs from MSP1 E3 D1 
Figure 8: EM image of empty MSP1 E3 D1 nanodisc (1 % PTA, 40 kX) (arrow indicates a 
stack of four discs of varying length seen from the side 
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Figure 8 shows the EM pictures of empty MSP1 E3 D1 nanodics (white bands against the dark 
background) prepared with 1 % PTA. The concentration of empty nanodiscs was found to be 
0.56 mg/ml and the LPR used for this preparation was “120”. It is observed that there are 
differences in diameter when compared with empty MSP₂ N₂ nanodiscs showed in fig 6 and 
empty MSP1 E3 D1 nanodiscs. The sizes of empty MSP₂ N₂ nanodisc were 16-18 nm and the 
stacks were very long (fig 6). The empty MSP1 E3 D1 nanodiscs sizes varied in size (<10-14 
nm) within the stacks that were short (e.g. Fig 8, arrow). This variation in size and the 
presence of large aggregates (that could be short stacks seen from top) needs to be solved.   
Practical limitations due to TEV protease size 
 
 
                                                                         
          
Figure 9a: 12 % SDS-PAGE analysis of 
AcTEV protease and MSP1 E3 D1 from 
Invitrogen 
Figure 9b: 12 % SDS-PAGE analysis of 
molecular weight difference of TEV protease 
(Sigma: 54 kDa, Invitrogen: 26-28 kDa) 
 
In protocols for insertion of a target protein into nanodiscs it was proposed that the Histidine 
tag on the MSP used for its purification should be cleaved off before reconstitution (6). 
However, several attempts were made to use cleaved MSP but no reconstitution was observed 
and hence the protein yield was investigated. Figure 9a shows a 12 % SDS-PAGE of MSP₁  
E₃   D₁, before and after cleavage but also the AcTEV protease is shown: Lane A is the 
chymotrypsinogen marker (25 kDa), Lane B is the AcTEV protease from Invitrogen (26-28 
kDa), Lane C is the crude uncleaved fraction of MSP₁	  E₃	  D₁ (32 kDa), Lane D is the MSP₁  E₃  
D₁ obtained after cleavage and purification and expected to be at 29 kDa. Severe loss of 
protein seemed to occur due to the cleavage and purification procedure (fig 9a Lane C and 
D). Perhaps this depended on problems with this enzyme batch not cleaving the His-tag as 
expected. It is furthermore not so good that the molecular weights of the TEV protease and 
MSP₁ E₃ D₁  are  similar  as  it  could  be  unclear  what  the  band  in  lane  D  (fig  9a)  actually  
shows (AcTEV protease or MSP₁ E₃ D₁). 
This lack of reconstitution together with the similarity in size of the TEV protease and MSP₁ 
E₃ D₁ made us to try two things: 1) The cleavage of His-tag from MSP₁ E₃ D₁ was 
performed after reconstitution 2) Another TEV protease (Sigma Aldrich) was used with 
molecular weight 54 kDa (fig 9b). 
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Result from reconstituted FLAP nanodiscs with TEV protease    
(Invitrogen) 
 
 
 
                                                                               A    B                    C 
  
 
Figure 10: Blue native page result of reconstitution of FLAP with MSP1 E3 D1 
 
 
Here, the cleavage of the His-tag from MSP₁ E₃ D₁ was performed after reconstitution but 
still with the AcTEV protease (fig 10). FLAP protein remains uncleaved inside the nanodisc 
since it does not contain the TEV protease cleavage site and can be used for purification to 
remove the empty cleaved nanodiscs since the crude containing both empty and reconstituted 
FLAP discs could not be used directly for structural or complex formation studies. Fig 10 
shows the result from the Blue native page gel (4-10 % Bis-tris gel). Lane C shows the crude 
uncleaved sample which contains both FLAP nanodiscs (ND-FLAP) and empty discs (E-
ND), whereas both lane A and B shows the cleaved and purified FLAP nanodiscs (ND-
FLAP). The molecular weight of the reconstituted FLAP nanodisc (and His-cleaved) was 
calculated to be 290 kDa at LPR 115 (Lane A). Lane A (and B) contains an extremely weak 
band of empty discs (calculated to 242 kDa) indicating that the AcTEV protease worked well. 
The clear single band in lane A and lane B showed that the reconstitution of FLAP into 
nanodiscs was successful. Hence it was expected that the EM pictures should show no 
stacking (cf fig 8) and only show separated discs. However, we could see some stacking and 
aggregation of discs (fig 11) despite the purity of the FLAP nanodiscs (fig 10, Lane A and B). 
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Figure 11: EM image of FLAP reconstituted into MSP1 E3 D1 nanodiscs (arrow indicates a 
stack of four discs seen from the side) (1 % PTA (55.6 kX) 
 
Result from cleaved reconstituted FLAP with TEV protease (Sigma) 
 
Since AcTEV protease (Invitrogen) used in the previous results seemed a problem at first, 
another engineered TEV protease of molecular weight (54 kDa) was used from Sigma. Also 
here, reconstitution of FLAP into MSP1 E3 D1nanodiscs was performed first and cleavage of 
the MSP₁ E₃ D₁ - His-tags secondly that leaves the His-tag on the FLAP (lacking a TEV 
cleavage site). Finally, separation was performed using a His-column (GE Healthcare). 
 
 
 
 
 
Fig 12: Blue native PAGE analysis of empty and cleaved reconstituted FLAP into 
 MSP₁ E₃ D₁ nanodiscs 
 
The main difference from Figure 11 is that Figure 12 shows the cleaved crude (lane A). In 
Figure 12, lane A sample shows the crude containing the TEV protease (not visible as a 
band), empty discs (at 242 kDa) and reconstituted discs (faint band above 242 kDa). Lane B 
(fig 12) shows that after purification on a His column, there was no presence of empty discs 
but only reconstituted FLAP nanodiscs expected at 290 kDa. This confirms that there is 
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successful cleavage activity. Lane C is the pure reconstituted disc which is eluted after buffer 
exchange using desalting column (ZEBA spin desalting column (40 MWCO)). 
The LPR used in this preparation was 108. Since the LPR 108 was observed to be too low, 
LPR 115 was experimented (fig 10). Fig 10 shows equal amount of empty discs and 
reconstituted FLAP nanodiscs.  
Western-blot results from a denaturing gel 
 
 
                                                      
        A                                                   B                                                  C 
Figure 13 (A) -Western blot of isolated FLAP, (B) -Western blot of FLAP reconstituted in 
nanodiscs, (C) - 15 % SDS-PAGE denaturing gel, Coomassie stained, after transfer of protein 
to the membrane for antibody detection as shown in B 
 
 
In order to confirm that the purified protein was FLAP and reconstituted discs contain the 
FLAP protein (cf. figs 10, 11 and 12), a western blot was performed. The primary antibody 
used in this experiment was anti ALOX 5AP/FLAP from rabbit IgG. One hour western blot 
kit purchased from Genscript Inc was used in this method since it was easier to use and time 
consumed for the entire experiment was less than that of the classical western blot method 
which usually takes 2-3 days. The process was initiated by running an SDS PAGE (15 %) 
denaturing gel followed by Western Blotting. Figure 13A shows the antibody detection of 
purified FLAP monomeric protein (18 kDa), fig 13B shows the FLAP monomer from 
reconstituted FLAP nanodiscs prepared from various concentrations of sodium cholate (i.e 20 
mM, 25 mM and 30 mM). In fig 13C it is observed that in lanes A, B and C, even after 
transfer from SDS-PAGE gel to the nitrocellulose membrane, protein is left in the gel 
corresponding to the FLAP monomer seen in fig 13B. It is also interesting to see the thick 
band of MSP protein in lane A (fig 13C) after denaturing of the reconstituted FLAP nanodisc. 
 
 
 
 
18 kDa 
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Western-blot result from a native gel 
The main change was that the initial gel run takes place in a native environment (fig 14). The 
remaining step till development remains the same (15). 
 
 
 
Figure 14 –Western blot analysis of purified FLAP nanodiscs prepared using MSP₁ E₃ D₁ 
 
 
Western blot confirmation of 5-LO 
 
Though, this project focuses on the reconstitution of FLAP into nanodiscs, it is the interaction 
with the 5-Lipoxygenase enzyme we are interested in considering the longer perspective of 
the project in the group. 5-LO was expressed and purified (as described in Methods section 
pg 16, 17). Apart from Western Blot tests of FLAP nanodisc formation, western blot was 
performed on 5-LO after purification. A 12 % SDS PAGE shows 5-LO at 78 kDa (fig 7, 15a). 
In figure 15b, both lane A and lane B contains 5-LO protein detected by the one hour western 
blot technique. The primary antibody used was rabbit IgG five lipoxygenase polyclonal 
antibody. 
 
                                                  
  
Figure 15a:  12 % SDS –PAGE of purified 5-
lipoxygenase 
Figure 15b: Western blot detection of 
5-lipoxygenase 
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EM pictures of pure reconstituted FLAP nanodisc 
 
EM pictures of FLAP nanodiscs (0.45 mg/ml) were taken with our JEOL 2100F 200 kV 
transmission electron microscope. Since the protein concentration was high, several dilutions 
were done and finally 0.15 mg/ml was found to be optimum for visualisation of discs in 
negative stain. PTA, UrAc and UrFo were used in the experiments. Each stain has distinct 
properties. 
Figures 16a and 16b show EM pictures of FLAP nanodiscs stained with 1 % PTA. This stain 
induces a stacking-like formation in the case of empty discs (see fig 8 a, b) (24) and fewer 
(fig 11) or almost no stacks in the reconstituted FLAP as in figure 16a and b. With PTA the 
side views of the nanodiscs are clearly seen as white band-like objects. The low number of 
stacks in fig 16a and 16b could indicate that the presence of FLAP prevent stacking, 
however, there was a lot of stacking in fig 11. It is difficult to say, however, what the medium 
dark areas in figure 16 represent (darkest is background). 
 
                                                                               
                                    16a                                                                   16b 
 
 
                                                           
Figure 16 a, b – EM pictures of reconstituted FLAP in MSP₁ E₃ D₁ nanodiscs stained with 1 
% PTA (69.5 kX) 
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In UrAc stained samples (fig 17a and b), pictures were of a surprise. There were top views of 
the discs as expected (24) as well as some stacking formation which was not expected for this 
stain (24 and C. Jegerschold personal communication). This raises questions and open 
discussions about the FLAP inside the disc. 
 
 
 
 
 
 
                                                                                                                       
                          17a                                   17b 
 
 
 
Figure 17 a, b – EM images of Reconstituted nanodisc stained with UrAc (69.5 kX), Arrow 
from fig 17 b shows the presence of stacked pattern of discs even with UrAc 
 
 
 
 
                                           
                                 18a                             18b 
 
Figure 18 a, b: EM images of FLAP protein in vesicles stained with UrAc (102 kX, CM120 
microscope at 120kV) (with permission from C. Jegerschold, unpublished results)  
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However, EM images of two-dimensional crystallisation trials of FLAP stained with UrAc 
shows a stacking formation (fig 18a and b, made by C. Jegerschold, unpublished results). In 
the so called two-dimensional crystallisation of FLAP, purified FLAP in detergent micelles 
and phospholipids solubilised in detergent were mixed followed by removal of the detergent 
by dialysis. A natural phosphocholine enriched extract from AVANTI co, USA was the lipid 
used during the experiment (C. Jegerschold personal communication). Fig 18a and 18b shows 
flattened stacked vesicles containing FLAP. This shows that the stacking formation of FLAP 
protein was seen earlier when it was stained with UrAc. Hence, it is observed that the 
stacking pattern may be the property of FLAP protein itself, irrespective of the negative stain 
UrAc. 
 
 
 
                                                                                              
                                 19a                         19b 
 
Figure 19a, b: FLAP reconstituted in nanodisc stained with 1 % Uranylformate (69.5 kX) 
 
 
Figure 19 a, b shows the reconstituted FLAP nanodisc sample stained with 1 % Uranyl 
Formate. As mentioned earlier, different negative stains have distinct properties. With Uranyl 
formate, in fig 19a, b it was noticed that there were very few stacking formation seen from 
the side (cf. arrow in fig 8a on empty disc stack and fig 11 on stack in a FLAP nanodisc 
sample). While comparing to the other stains, in UrFo the sample looks more homogenous. 
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Conclusion 
 
From the results, the confirmation tests such as blue native page and western blot provide 
evidence of the presence of FLAP in the nanodiscs. Though TEM pictures did not provide 
concrete evidence of presence of FLAP in the nanodiscs, images obtained were equally 
interesting for further structural analysis. TEM images of FLAP nanodisc bound with FLAP 
antibody will also provide additional evidence of the presence of FLAP inside the nanodisc. 
FLAP reconstituted in nanodiscs will be used to make the whole functional complex with 
5LO in vitro for studies of the structure using so called single particle cryoEM analysis. Next 
step is to determine the activity of this complex. The results from activity and structure 
measurements could together provide information on the mechanism for the involvement of 
FLAP in the production of leukotrienes from arachidonic acid. Also other proteins in the 
leukotriene pathway are believed to associate with FLAP or 5-LO and such complexes could 
also be investigated based on the results in this thesis. On a longer term, this nanodisc 
approach to study complex-formation between transmembrane proteins and soluble proteins 
may provide information concerning membrane dependent reactions and might bring vital 
breakthrough to identify drugs, thereby alleviating many inflammatory diseases such as 
asthma and atherosclerosis.  
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Popular science abstract 
 
Title 
 
Insertion of transmembrane 5-lipoxygenase activating protein (FLAP) into nanodiscs: 
towards structure function studies of complex formation with soluble proteins. 
 
Background 
 
Leukotrienes are specialized lipid molecules found abundant in white blood cells, so called 
leukocytes important in our immune system. It is important to remember that inflammation is 
a vital process in the body (normally) in the combat in cases of infection or trauma or some 
kind of irritation. After the inflammation phase with a lot of specific reactions comes the 
“resolution phase” to heal completely. Sometimes inflammation is chronic in certain diseases 
and then needs to be treated. For example, cardiovascular diseases such as asthma and 
atherosclerosis are chronic and needs to be treated on a long term basis. The origin of such 
diseases initiates with the above said leukotriene molecules and their formation can be 
prevented by leukotriene inhibitors. 
 
Biosynthetic pathway 
 
To prevent the diseases, it is important to know about the biological pathway of leukotrienes. 
Leukocytes have the capability for the complete bio-synthesis of leukotrienes from 
arachidonic acid, an unsaturated fatty acid found abundant in liver and brain. The leukocytes 
can be activated by a variety of external stimuli such as antigens, oxidants and immune 
complexes that trigger an increase in the intracellular concentration of calcium. This 
promotes the transfer of several proteins to the surface of the nuclear membranes like 5-LO 
(5-lipoxygenase) where a membrane embedded protein FLAP (Five lipoxygenase activating 
protein) is located.  Ultimately, arachidonic acid is converted to the leukotriene derivative 
LTA₄ with the assistance from 5-LO and FLAP. LTA₄ is then converted to other leukotrienes 
that act as chemo attractants for specific white blood cells to the site of inflammation or cause 
mucus secretion in the airways.  
 
Function of FLAP (Five lipoxygenase activating protein) 
 
In the leukotriene synthesis pathway, the only function of FLAP is to assist in the transfer of 
arachidonic acid from the membrane to 5-LO. In fact, FLAP does not have any enzymatic 
activity on its own. It is a protein embedded in the nuclear membrane whereas 5-LO is 
recruited to the membrane by calcium but it is unclear if they physically interact or how 
arachidonic acid presented to 5-LO. 
Nanodiscs 
Since the complex formation between the integral membrane protein FLAP and soluble 
protein 5-LO depends on the presence of a membrane, we thought that the novel nanodiscs 
would be suitable for this study. Nanodiscs are circular fragments of phospholipid bilayer 
 36 
encircled by two copies of membrane scaffold proteins (MSPs). The nanodiscs are small 
soluble pieces of membranes of defined sizes and have lot of advantages for structural and 
functional studies. To make it simple, nanodiscs resembles a compact disc. 
 
Aim  
The main aim of this project is to develop a protocol for the generation of nanodiscs 
containing five lipoxygenase activating protein (FLAP) and to verify the presence of FLAP 
protein in the nanodiscs. 
 
Project  
The functional unit of FLAP is a homotrimer of 54 kDa that was purified in the detergent 
DDM. Two derivatives of membrane scaffold protein such as MSP₁ E₃ D₁ and MSP₂ N₂ 
were expressed and purified. MSP₂ N₂ should give 17 nm diameter discs, however it turned 
out to be unstable in our hands and the smaller version of MSP named MSP₁ E₃ D₁ was used 
for the project. This gives 12.8 nm diameter discs and provides just enough space for one 
FLAP and one 5-LO. So called reconstitution of FLAP into MSP₁ E₃ D₁ nanodiscs was done 
by solubilization of the lipid POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) with 
detergent (sodium cholate) followed by addition of MSP₁ E₃ D₁ and FLAP in various ratios 
to optimize the protocol. The reason for choosing the lipid POPC is that 5-LO binds to 
phospholipids that specifically contain an unsaturated acyl chain at the sn-2 position like the 
oleoyl in POPC.  Cleavage of His-tag from MSP₁ E₃ D₁ was performed with AcTEV 
protease after reconstitution of FLAP in MSP₁ E₃ D₁ nanodisc. FLAP protein remains 
uncleaved inside the nanodisc since it does not contain the TEV protease cleavage site. 
Purification was done by His-column and purified reconstituted FLAP nanodiscs were stored 
at 4 °C.  
 
Results 
Gel electrophoresis both in denaturing and native conditions followed by Western Blot gave 
clear evidence that FLAP was present in the nanodiscs. Negative stain EM (Electron 
Microscopy) was also used to visualize but was less conclusive. 
 
Conclusions 
This project aim, the protocol for production of nanodiscs containing FLAP was achieved. 
This experiment provides the first step in the attempt to answer the biological question if 5-
LO and FLAP interact physically and how arachidonic acid is presented to 5-LO using 
nanodiscs as a membrane model. 
 
Future 
Many protein complexes in the cells carry out their function on a membrane surface or within 
the membrane but very little is still known about these reactions. The simple way to prepare 
model membranes, the nanodiscs, by just mixing a membrane scaffold protein (MSP) and 
lipids and for some projects also a target membrane protein, makes the study of membrane 
proteins in some ways easier. Both sides of the nanodisc membrane surfaces are accessible 
and thus also both sides of a membrane protein inside the disc. This project contributes to the 
studies of complex formation between integral membrane proteins and soluble proteins. 
Finally, the research project not only teaches us about FLAP at structural and functional 
level, but could contribute in pharmaceutica research for many cardio vascular diseases 
which possess a threat to the society. 
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Appendices 
 Appendix 1  
 
MSP₁E₃D₁ sequence 
 
MGHHHHHHHDYDIPTTENLYFQGSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMS
KDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLS
PLGEEMRDRARAHVDALRTHLAPYLDDFQKKWQEEMELYRQKVEPLRAELQEGAR
QKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGA
RLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ. 
 
 
 
MSP₂N₂ sequence 
 
 
MGHHHHHHHDYDIPTTENLYFQGSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMS
KDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLS
PLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKAT
EHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQGTPVTQEFWDN
LEKETEGLRQMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGA
RQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGG
ARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ  
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 Appendix 2 
 
Buffers and chemicals preparation 
 
• LB medium: 
 
LB broth base powder (Invitrogen) and distilled water. 
 
• TB medium: 
 
Terrific broth powder (Invitrogen), 4 mL glycerol, and distilled water. 
 
• MSP buffer preparation: 
 
• Wash buffer :  40 mM Tris HCl  pH 7.8 0.3 M NaCl 1 % triton pH 8.0 
 
• Wash buffer 2:  40 mM Tris HCl  pH 7.8 0.3 M NaCl 50 mM cholate pH 8.0, 
                                      20mM    Imidazole 
 
 
• Wash buffer 3:  40 mM Tris HCl  pH 7.8 0.3 M NaCl 50 mM Imidazole pH 8.0 
 
• Elution buffer:  40 mM Tris HCl pH 7.8 0.3 M NaCl 0.5 M Imidazole. 
 
• MSP standard buffer: 20 mM Tris HCl pH 7.8 0.1 M NaCl 0.5 mM EDTA pH 7.4. 
 
 
FLAP buffer preparation: 
 
• FLAP equilibration buffer: 25 mM Tris HCl pH 7.8, 10 % glycerol, 0.1 % DDM    
                                            5 mM β-Mercaptothanol. 
 
• FLAP wash buffers: (all buffers contains 0.03 % DDM, and 5 mM β - ME) 
 
• Wash buffer 1: 25 mM Tris HCl pH 7.8, 10 % glycerol, 0.1 M NaCl,  
                                    20 mM Imidazole. 
 
• Wash buffer 2: 25 mM Tris HCl pH 7.8, 10 % glycerol, 0.5 M NaCl, 50 mM  
                         Imidazole, 0.5 M NaCl. 
 
• FLAP Elution buffer : 25 mM Tris HCl pH 7.8, 10 % glycerol, 0.5 M NaCl,  
                                               300 mM Imidazole. 
 
• PD-10 column : 25 mM Tris HCl pH 7.8, 10 % glycerol, 0.1 M NaCl, 0.03 % DDM,   
                         5 mM β - ME) 
 
• NI-IMAC column regeneration: 50 mM Tris HCl pH 7.8, 50 mM EDTA. 
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5-LO buffer preparation: 
 
• Lysis buffer : 50 mM Tris pH 8  2 mM EDTA 2 mM β - ME 
 
• Wash buffer 2 : 50 mM Tris pH 8 2 mM EDTA  2 mM β - ME, 0.5 M NaCl 
 
 
• Wash buffer 1 : 50 mM Tris pH 8 2 mM EDTA 2 mM β - ME, 0.1 M NaCl 
 
• AMP elution buffer : 12 mM AMP 50 mM Tris pH: 8.0 2 mM EDTA 
                                             5 mM β – Me 0.1 M NaCl 
                                          
 
• ATP elution buffer : 12 mM ATP 50mM Tris pH: 8.0 2mM EDTA 5mM β - Me   
                                            0.1 M NaCl 
 
Western blot transfer buffer: 
 
• 1 X Tris glycine (with SDS): 0.05 M Tris, 0.19 M Glycine 0.1 % SDS) 
 
Phosphate buffer: 
 
• 8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4, 0.24 g of KH2PO4 pH: 7.4 adjusted 
to 1 L. 
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Appendix 3 
 
Procedure for reconstitution of FLAP 
 
i. xx µl of POPC (32.9 mM) was dried under a stream of nitrogen gas to give a thin 
layer of lipid film desiccated in a high vacuum overnight. 
 
ii. Next day, the lipid film was resuspended with 65.8 mM sodiumcholate and then 
sonicated and vortexed until the solution is transparent. 
 
iii. In an eppendorf tube, xxx µl of FLAP protein at xx µM and xxx µl of MSP₁	  E₃	  D₁ at 
xx µM was added to the detergent solubilised lipid (xx µl). 
 
iv. xxx µl of sodium cholate from the initial concentration at 232 mM was added to the 
above recipe to give xx mM final concentration. 
 
v. To attain the total volume of xxx µl, xx µl of MSP standard buffer was added  
           (20 mM Tris-HCL, 0.1 M NaCl, 0.5 mM EDTA, pH 7.4). 
 
vi. Reconstituted FLAP nanodisc sample was incubated in ice for 60 minutes. 
 
vii. Since reconstituted FLAP and nanodiscs were solubilised with detergents (DDM and 
sodium cholate respectively), Bio-beads SM-2(two-third to the volume of the final 
mixture, i.e. xxx µl) were added to remove them and incubated at 4 °C overnight.  
 
 
viii. It is necessary that the final detergent concentration in the reconstituted mixture 
should be in the range of 12-40 mM. In this protocol, the final sodium cholate 
concentration was xx mM. 
 
ix. LPR plays a significant role in the reconstitution of membrane proteins. In this 
project, several titrations were performed with different LPRs such as 108, 112.5, 
115,120,125;. Finally, the optimised LPR was xxx. 
 
x. The molar ratio of MSP₁  E₃  D₁: FLAP monomer: POPC was x:x:x 
 
xi. The final concentration of MSP₁  E₃  D₁ and FLAP in the nanodisc was calculated at 
xx µM and xx µM respectively. 
 
xii. The prepared reconstituted FLAP nanodisc was stored at 4 °C and used within a 
month or frozen to -80 °C. 
